Advertisement
U.S. markets open in 2 hours 29 minutes

AstraZeneca PLC (AZN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
65.85-0.46 (-0.69%)
At close: 04:00PM EDT
65.30 -0.55 (-0.84%)
Pre-Market: 07:00AM EDT
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
45,811,000
45,811,000
44,351,000
37,417,000
26,617,000
Cost of Revenue
8,268,000
8,268,000
12,391,000
12,437,000
5,299,000
Gross Profit
37,543,000
37,543,000
31,960,000
24,980,000
21,318,000
Operating Expense
28,821,000
28,821,000
27,448,000
25,119,000
17,402,000
Operating Income
8,722,000
8,722,000
4,512,000
-139,000
3,916,000
Net Non Operating Interest Income Expense
-1,288,000
-1,288,000
-1,249,000
-1,233,000
-1,189,000
Pretax Income
6,899,000
6,899,000
2,501,000
-265,000
3,916,000
Tax Provision
938,000
938,000
-792,000
-380,000
772,000
Net Income Common Stockholders
5,955,000
5,955,000
3,288,000
112,000
3,196,000
Diluted NI Available to Com Stockholders
5,955,000
5,955,000
3,288,000
112,000
3,196,000
Basic EPS
1.90
-
1.06
0.04
1.22
Diluted EPS
1.89
-
1.05
0.04
1.22
Basic Average Shares
3,097,500
-
3,096,000
2,836,000
2,624,000
Diluted Average Shares
3,120,000
-
3,120,000
2,854,000
2,626,000
Total Operating Income as Reported
8,193,000
8,193,000
3,757,000
1,056,000
5,162,000
Rent Expense Supplemental
301,000
301,000
268,000
262,000
228,000
Total Expenses
37,089,000
37,089,000
39,839,000
37,556,000
22,701,000
Net Income from Continuing & Discontinued Operation
5,955,000
5,955,000
3,288,000
112,000
3,196,000
Normalized Income
6,375,540
6,375,540
3,888,210
-852,710
2,192,425
Interest Income
301,000
301,000
81,000
43,000
83,000
Interest Expense
1,589,000
1,589,000
1,330,000
1,276,000
1,272,000
Net Interest Income
-1,288,000
-1,288,000
-1,249,000
-1,233,000
-1,189,000
EBIT
8,488,000
8,488,000
3,831,000
1,011,000
5,188,000
EBITDA
13,422,000
13,422,000
9,085,000
5,113,000
8,084,000
Reconciled Cost of Revenue
8,268,000
8,268,000
12,391,000
12,437,000
5,299,000
Reconciled Depreciation
4,934,000
4,934,000
5,254,000
4,102,000
2,896,000
Net Income from Continuing Operation Net Minority Interest
5,955,000
5,955,000
3,288,000
112,000
3,196,000
Total Unusual Items Excluding Goodwill
-489,000
-489,000
-741,000
1,191,000
1,250,000
Total Unusual Items
-489,000
-489,000
-741,000
1,191,000
1,250,000
Normalized EBITDA
13,911,000
13,911,000
9,826,000
3,922,000
6,834,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-68,460
-68,460
-140,790
226,290
246,425